Peter A. Lambert

10.0k total citations · 1 hit paper
199 papers, 7.1k citations indexed

About

Peter A. Lambert is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Peter A. Lambert has authored 199 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Infectious Diseases, 56 papers in Molecular Biology and 34 papers in Epidemiology. Recurrent topics in Peter A. Lambert's work include Antimicrobial Resistance in Staphylococcus (41 papers), Antibiotic Resistance in Bacteria (29 papers) and Bacterial biofilms and quorum sensing (24 papers). Peter A. Lambert is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (41 papers), Antibiotic Resistance in Bacteria (29 papers) and Bacterial biofilms and quorum sensing (24 papers). Peter A. Lambert collaborates with scholars based in United Kingdom, United States and Denmark. Peter A. Lambert's co-authors include T. Worthington, Barbara R. Conway, T.S.J. Elliott, Michael R. Brown, A.L. Casey, T.J. Karpanen, J. Baddiley, Emma Hendry, Ann B. Vernallis and Thomas Elliott and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Peter A. Lambert

194 papers receiving 6.7k citations

Hit Papers

Post-COVID-19 Adaptations; the Shifts Towards Online Lear... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Lambert United Kingdom 44 2.1k 1.5k 1.1k 919 789 199 7.1k
Kim Ys South Korea 56 3.2k 1.5× 2.8k 1.9× 1.3k 1.2× 1.8k 2.0× 884 1.1× 504 16.8k
Thomas L Holland United States 33 2.6k 1.2× 3.6k 2.4× 597 0.6× 1.3k 1.4× 555 0.7× 130 8.8k
G. Pulverer Germany 37 2.2k 1.0× 1.5k 1.0× 812 0.8× 1.2k 1.3× 313 0.4× 430 6.4k
J. M. T. Hamilton‐Miller United Kingdom 39 1.8k 0.8× 2.0k 1.4× 1.2k 1.1× 1.7k 1.8× 895 1.1× 246 6.9k
Ian Chopra United Kingdom 37 3.2k 1.5× 1.5k 1.0× 2.2k 2.0× 628 0.7× 738 0.9× 89 8.2k
Giovanni Di Bonaventura Italy 36 3.1k 1.5× 1.1k 0.8× 765 0.7× 738 0.8× 784 1.0× 119 6.3k
Hans J. Nelis Belgium 46 3.4k 1.6× 1.5k 1.0× 572 0.5× 848 0.9× 727 0.9× 194 8.2k
Anthony Coates United Kingdom 43 3.2k 1.5× 2.3k 1.6× 914 0.9× 1.6k 1.7× 432 0.5× 150 6.7k
Hossein Samadi Kafil Iran 56 3.7k 1.7× 1.4k 0.9× 2.0k 1.9× 1.0k 1.1× 2.1k 2.6× 426 12.1k
Milan Kolář Czechia 37 1.5k 0.7× 590 0.4× 968 0.9× 468 0.5× 568 0.7× 194 8.6k

Countries citing papers authored by Peter A. Lambert

Since Specialization
Citations

This map shows the geographic impact of Peter A. Lambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Lambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Lambert more than expected).

Fields of papers citing papers by Peter A. Lambert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Lambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Lambert. The network helps show where Peter A. Lambert may publish in the future.

Co-authorship network of co-authors of Peter A. Lambert

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Lambert. A scholar is included among the top collaborators of Peter A. Lambert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Lambert. Peter A. Lambert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lightbody, Kirsty L., Andrew Austin, Peter A. Lambert, et al.. (2023). Validation of a serum ELISA test for cyathostomin infection in equines. International Journal for Parasitology. 54(1). 23–32. 10 indexed citations
2.
Lopeman, Rose C., James Harrison, Daniel L. Rathbone, et al.. (2020). Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus. Scientific Reports. 10(1). 928–928. 43 indexed citations
3.
Karpanen, T.J., A.L. Casey, Barbara R. Conway, Peter A. Lambert, & Tom SJ Elliott. (2011). Antimicrobial activity of a chlorhexidine intravascular catheter site gel dressing. Journal of Antimicrobial Chemotherapy. 66(8). 1777–1784. 19 indexed citations
4.
Lambert, Peter A., et al.. (2009). Preoperative skin preparation: a historical perspective. British Journal of Hospital Medicine. 70(10). 579–582. 7 indexed citations
5.
Casey, A.L., Peter A. Lambert, & Thomas Elliott. (2007). Staphylococci. International Journal of Antimicrobial Agents. 29. S23–S32. 77 indexed citations
6.
Watkin, Richard, Sue Lang, Peter A. Lambert, W A Littler, & Thomas Elliott. (2006). The serological diagnosis of staphylococcal infective endocarditis. Journal of Infection. 53(5). 301–307. 8 indexed citations
7.
Worthington, T., et al.. (2006). P9.01 Susceptibility of Germinating Clostridium difficile Spores to 70% Ethanol. Journal of Hospital Infection. 64. S47–S47. 2 indexed citations
9.
Lang, Sue, Richard Watkin, Peter A. Lambert, W A Littler, & T.S.J. Elliott. (2004). Detection of bacterial DNA in cardiac vegetations by PCR after the completion of antimicrobial treatment for endocarditis. Clinical Microbiology and Infection. 10(6). 579–581. 32 indexed citations
10.
Lambert, Peter A.. (2000). Lipid S, a novel Staphylococcus epidermidis exocellular antigen with potential for the serodiagnosis of infections. FEMS Immunology & Medical Microbiology. 29(3). 195–202. 2 indexed citations
11.
Lambert, Peter A., et al.. (2000). Identification of a novel antigen fromStaphylococcus epidermidis. FEMS Immunology & Medical Microbiology. 29(3). 213–220. 58 indexed citations
12.
Lambert, Peter A., T. Worthington, S. E. Tebbs, & T.S.J. Elliott. (2000). Lipid S, a novelStaphylococcus epidermidisexocellular antigen with potential for the serodiagnosis of infections. FEMS Immunology & Medical Microbiology. 29(3). 195–202. 22 indexed citations
13.
Twentyman, P R, et al.. (1998). Chemical synthesis and biological properties of novel fluorescent antifolates in pgp- and mrp-overexpressing tumour cell lines. Biochemical Pharmacology. 56(7). 807–816. 5 indexed citations
14.
Schalk, Isabelle J., et al.. (1996). Specific photoaffinity labelling of a ferripyoverdin outer membrane receptor of Pseudomonas aeruginosa. FEBS Letters. 396(2-3). 243–247. 5 indexed citations
15.
Lambert, Peter A., et al.. (1992). Enzyme-linked immunosorbent assay for the detection of antibodies to exocellular proteins ofStaphylococcus aureusin bone infection. FEMS Microbiology Letters. 100(1-3). 67–70. 6 indexed citations
16.
Lambert, Peter A., et al.. (1991). Evaluation of a small-scale method for the extraction of the K88 antigen from enterotoxigenicEscherichia coli. FEMS Microbiology Letters. 78(1). 81–84. 2 indexed citations
17.
Lambert, Peter A., et al.. (1990). Effect of in vivo growth conditions upon expression of surface protein antigens inEnterococcus faecalis. FEMS Microbiology Letters. 64(1). 51–54. 14 indexed citations
18.
Lambert, Peter A.. (1982). Exposure of outer membrane proteins on the surface of Pseudomonas aeruginosa PA01 revealed by labelling with [125I]lactoperoxidase. FEMS Microbiology Letters. 14(1). 43–45. 1 indexed citations
19.
Lambert, Peter A., et al.. (1982). Exposure of outer membrane proteins on the surface ofPseudomonas aeruginosaPA01 revealed by labelling with [125I]lactoperoxidase. FEMS Microbiology Letters. 14(1). 43–45. 24 indexed citations
20.
Lambert, Peter A.. (1978). 2 Membrane-Active Antimicrobial Agents. Progress in medicinal chemistry. 15. 87–124. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026